Ausgabe 3/2021
Inhalt (21 Artikel)
Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services
W. F. Lems, J. Paccou, J. Zhang, N. R. Fuggle, M. Chandran, N. C. Harvey, C. Cooper, K. Javaid, S. Ferrari, K. E. Akesson, K.E. Akesson, M.L. Brandi, M. Chandran, T. Chevalley, C. Cooper, P. Fardellone, S. Goemaere, N.C. Harvey, G. Holzer, M.K. Javaid, W. Lems, E.M. Lewiecki, G. Lyritis, N. Napoli, J. Paccou, S. Silverman, M. Sosa, T. Thomas
Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials
D. Rosenberg, T. Avni, G. Tsvetov, A. Gafter-Gvili, T. Diker-Cohen
C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches
H. Mun, B. Liu, T. H. A. Pham, Q. Wu
Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteoporosis
B. C. S. de Vries, J. H. Hegeman, W. Nijmeijer, J. Geerdink, C. Seifert, C. G. M. Groothuis-Oudshoorn
Exploring thoracic kyphosis and incident fracture from vertebral morphology with high-intensity exercise in middle-aged and older men with osteopenia and osteoporosis: a secondary analysis of the LIFTMOR-M trial
A. T. Harding, B. K. Weeks, C. Lambert, S. L. Watson, L. J. Weis, B. R. Beck
FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture
N. Sagalla, C. Colón-Emeric, R. Sloane, K. Lyles, J. Vognsen, R. Lee
Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients
L. Vehmanen, H. Sievänen, P. Kellokumpu-Lehtinen, R. Nikander, R. Huovinen, J. Ruohola, H.M. Penttinen, M. Utriainen, K. Tokola, C. Blomqvist, T. Saarto
Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome
N. Hong, E. Siglinsky, D. Krueger, R. White, C. O. Kim, H. C. Kim, Y. Yeom, N. Binkley, Y. Rhee, B. Buehring
Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial
M. Osaki, R. Okuda, Y. Saeki, T. Okano, K. Tsuda, T. Nakamura, Y. Morio, H. Nagashima, H. Hagino
Incidence and circumstances of falls among middle-aged women: a cohort study
M. Wang, F. Wu, M. L. Callisaya, G. Jones, T. Winzenberg
Sleep duration and bone health measures in older men
C. M. Swanson, P. J. Blatchford, K. L. Stone, J. A. Cauley, N. E. Lane, T. S. Rogers-Soeder, S. Redline, D. C. Bauer, K. P. Wright Jr, M. E. Wierman, W. M. Kohrt, E. S. Orwoll
Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case–control studies using a national sample cohort
J.W. Lee, C. Min, C.H. Bang, B.C. Kwon, H.G. Choi
Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women
L. M. Smith, J. C. Gallagher
Functional electrical stimulation (FES)–assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury
Y. Fang, L.R. Morse, N. Nguyen, R.A. Battaglino, R.F. Goldstein, K.L. Troy
Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture
K. Zhu, J. Zhang, C. Zhang, Z. Zhao, J. Gao, X. Li, X. Xia, X. Xu, T. Zhang, J. Guan
Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study
A. R. Zullo, Y. Lee, C. Lary, L. A. Daiello, D. P. Kiel, S. D. Berry
Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling
R. Winzenrieth, M.S. Ominsky, Y. Wang, L. Humbert, R.J. Weiss
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
E. Söreskog, I. Lindberg, J.A. Kanis, K.E. Åkesson, D. Willems, M. Lorentzon, O. Ström, P. Berling, F. Borgström
Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
M. Hiligsmann, S. Maggi, N. Veronese, L. Sartori, J.-Y. Reginster
In memory of Harry K Genant
C. Cooper, P. Halbout, B. Dawson-Hughes, N.C. Harvey, J.A. Kanis, J.-Y. Reginster, R. Rizzoli
Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture
N. E. Lane, K. Saag, T. J. O’Neill, M. Manion, R. Shah, U. Klause, R. Eastell